Logo video2dn
  • Сохранить видео с ютуба
  • Категории
    • Музыка
    • Кино и Анимация
    • Автомобили
    • Животные
    • Спорт
    • Путешествия
    • Игры
    • Люди и Блоги
    • Юмор
    • Развлечения
    • Новости и Политика
    • Howto и Стиль
    • Diy своими руками
    • Образование
    • Наука и Технологии
    • Некоммерческие Организации
  • О сайте

Видео ютуба по тегу Trial: Codebreak 100

Overall survival in the Phase II CodeBreaK 100 trial in NSCLC
Overall survival in the Phase II CodeBreaK 100 trial in NSCLC
Phase II CodeBreak 100 trial of sotorasib in advanced NSCLC
Phase II CodeBreak 100 trial of sotorasib in advanced NSCLC
CodeBreak 200 | Sotorasib | A Negligent trial that violated randomization!
CodeBreak 200 | Sotorasib | A Negligent trial that violated randomization!
KRAS-mutant NSCLC: CodeBreak 100 trial of sotorasib
KRAS-mutant NSCLC: CodeBreak 100 trial of sotorasib
KRYSTAL-1 and CodeBreak 100: targeting KRAS G12C in lung cancer
KRYSTAL-1 and CodeBreak 100: targeting KRAS G12C in lung cancer
CodeBreak 100: sotorasib in KRAS-mutated NSCLC
CodeBreak 100: sotorasib in KRAS-mutated NSCLC
CodeBreaK100 trial: Evaluating Sotorasib in pretreated KRAS p.G12C mNSCLC
CodeBreaK100 trial: Evaluating Sotorasib in pretreated KRAS p.G12C mNSCLC
CodeBreaK 100: detecting mechanisms of intrinsic resistance by ctDNA
CodeBreaK 100: detecting mechanisms of intrinsic resistance by ctDNA
CodeBreak 100: assessing sotorasib in patients with KRAS p.G12C-mutant pancreatic cancer
CodeBreak 100: assessing sotorasib in patients with KRAS p.G12C-mutant pancreatic cancer
ASCO 2021 Lung Recap: CodeBreak 100: Sotorasib in KRAS G12C Mutation
ASCO 2021 Lung Recap: CodeBreak 100: Sotorasib in KRAS G12C Mutation
CodeBreaK 100/101 First report of safety and efficacy of sotorasib + pembrolizumab or atezolizum...
CodeBreaK 100/101 First report of safety and efficacy of sotorasib + pembrolizumab or atezolizum...
CodeBreaK 100: Patient-reported outcomes evaluating sotorasib in KRAS p.G12C mNSCLC
CodeBreaK 100: Patient-reported outcomes evaluating sotorasib in KRAS p.G12C mNSCLC
CodeBreaK 101: sotorasib, panitumumab, and FOLFIRI in KRAS G12C mCRC
CodeBreaK 101: sotorasib, panitumumab, and FOLFIRI in KRAS G12C mCRC
History of KRAS-targeting in clinical trials
History of KRAS-targeting in clinical trials
What the New KRAS Inhibitor Means for Lung Cancer - Medpage Today
What the New KRAS Inhibitor Means for Lung Cancer - Medpage Today
The Truth About Randomized Controlled Trials in Cancer Medicine | Ethical vs Unethical Studies
The Truth About Randomized Controlled Trials in Cancer Medicine | Ethical vs Unethical Studies
Sotorasib achieved clinically meaningful activity in KRAS G12C-mutated advanced pancreatic cancer
Sotorasib achieved clinically meaningful activity in KRAS G12C-mutated advanced pancreatic cancer
ASCO 2021 Lung Recap: Poseidon Trial: Durvalumab +/- Tremelimumab vs. Chemo Alone
ASCO 2021 Lung Recap: Poseidon Trial: Durvalumab +/- Tremelimumab vs. Chemo Alone
WCLC 2021 highlights
WCLC 2021 highlights
Clinical Trials for Pancreatic Cancer
Clinical Trials for Pancreatic Cancer
Следующая страница»
  • О нас
  • Контакты
  • Отказ от ответственности - Disclaimer
  • Условия использования сайта - TOS
  • Политика конфиденциальности

video2dn Copyright © 2023 - 2025

Контакты для правообладателей [email protected]